Xiongxiong Lu

机构：Zhengzhou University · ORCID：0000-0001-7594-0329

发表论文 51 篇 · 总被引 1085 次 · h-index 18

代表论文

• Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma (2022 · Cell chemical biology · 被引 62)
• Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study (2022 · The Lancet Regional Health - Western Pacific · 被引 58)
• PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5 (2021 · Human Cell · 被引 51)
• Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication (2024 · Journal of Experimental & Clinical Cancer Research · 被引 36)
• Machine learning algorithms as early diagnostic tools for pancreatic fistula following pancreaticoduodenectomy and guide drain removal: A retrospective cohort study (2022 · International Journal of Surgery · 被引 30)
• Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort (2021 · EBioMedicine · 被引 26)